Arcus Biosciences, Inc.
RCUS
Jodie situation report
Arcus Biosciences, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.
- Company reports an additional drawdown under the Hercules agreement increased interest expense; Hercules facility is $250M and contains covenants including minimum cash (begin July 2027) and net product revenue tests.
Invalidation: The isolated read changes if RCUS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind RCUS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
GILDGilead Sciences, Inc.partnerMay 5, 2026 ▾
“TIGIT Program (domvanalimab) • In December 2025, we announced the discontinuation of the Phase 3 STAR-221 study, conducted in partnership with Gilead and Taiho, evaluating a domvanalimab-based combination in upper gastrointestinal cancers due to futility: ◦ T…”
AZNAstraZeneca PLCpartnerOct 28, 2025 ▾
“In October 2025, we announced eVOLVE-RCC02, a Phase 1b/3 study sponsored and operationalized by AstraZeneca, evaluating casdatifan plus volrustomig, AstraZeneca's investigational anti-PD-1/CTLA-4 bispecific antibody, in first-line, metastatic clear cell renal…”
Depended on by
GILDGilead Sciences, Inc.investeeMay 7, 2026 ▾
“For equity investments in our strategic partners, such as in connection with our collaborations with Arcus Biosciences, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
RCUS is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.